Numbing for sickle cell pain crisis: a study
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests whether numbing a specific area (regional anesthesia) can reduce inflammation and pain during a sickle cell pain crisis. It may offer a new way to manage severe pain without strong medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You are currently having a vaso-occlusive crisis (pain crisis from sickle cell disease)
- You are not pregnant or breastfeeding
- You have not had a blood transfusion in the last 3 months
- You are covered by French social security or similar
- You are not in a protected legal situation (e.g., under guardianship)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
This study looks at how children with sickle cell disease experience pain crises (severe pain episodes that often require hospital care). Researchers want to understand what happens during these crises, which might help improve care and treatment.
This trial tests whether adding acupuncture to standard pain treatments can help manage pain in people with sickle cell disease. It involves brain scans, questionnaires, and acupuncture sessions to see if this approach reduces pain and improves quality of life.
This study looks at what causes pain in people with sickle cell disease. They hope to learn more about pain patterns to better help patients manage it.
This trial tests an intravenous medicine called L-citrulline for young people with sickle cell disease who are in the emergency department for a painful crisis (vaso-occlusive crisis). It aims to see if it can ease the pain and help you recover faster.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
Hear when a new Sickle Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.